QQQ3.61%

Trending

ADBE11.41%

home Symbol DOCSnews

DOCSDoximity Inc

$20.19

$0.22

(1.09%)

Today

Closed $20.02

$0.1676

(0.84%)

After Hours

Updated: 06:28 PM EDT

Reported EarningsMay 13

Mkt Cap$3.7B

Vol3.03M

Fundamentals

Mkt Cap

$3.7B

Volume

52W High

$76.51

52W Low

$17.15

PE Ratio

20.63

Avg. Volume

5.71M

EPS (Annual)

$0.9849

Rev/Employee

$732,798.86

Earnings

May 13

Bearish Sentiment

How do you feel about DOCS?

Info

News

all

press releases

DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm PR Newswire LOS ANGELES, June 11, 2026 LOS ANGELES, June 11, 2026 /PRNewswire/ --The Schall Law...

PR Newswire

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS PR Newswire NEW YORK, June 11, 2026 NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is...

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is...

PR Newswire

DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc. (Doximity or the Company) (NYSE: DOCS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...

Business Wire

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?

OPRX and DOCS are betting big on AI-driven healthcare engagement as cautious pharma spending pressures near-term growth.

Zacks

Doximity: A Strong Contender or Vulnerable to Disruption?

Explore the exciting world of Doximity (NYSE: DOCS) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of Ap...

Nasdaq News: Markets

Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?

Key PointsThe market seems concerned that AI could replace some of Doximity's solutions for the medical community...

Nasdaq News: Markets

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS PR Newswire NEW YORK, May 21, 2026 NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is...

PR Newswire

Doximity to Present at the William Blair 46th Annual Growth Stock Conference

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026 at 4:40 p.m. Central Time. About Doximity Founded in 2010...

Business Wire

OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?

OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.

Zacks

...

Advertisement|Remove ads.